Cargando…

4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole

The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromo­succinamide with 5,6-dimethyl-2-(thio­phen-2-yl)-1-[(thio­phen-2-yl)meth­yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo­thio­phen-2-yl substituent with a refined major:minor occupanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Geiger, H. Cristina, Donohoe, James S., Geiger, David K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998606/
https://www.ncbi.nlm.nih.gov/pubmed/24826179
http://dx.doi.org/10.1107/S160053681400628X
_version_ 1782313398239756288
author Geiger, H. Cristina
Donohoe, James S.
Geiger, David K.
author_facet Geiger, H. Cristina
Donohoe, James S.
Geiger, David K.
author_sort Geiger, H. Cristina
collection PubMed
description The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromo­succinamide with 5,6-dimethyl-2-(thio­phen-2-yl)-1-[(thio­phen-2-yl)meth­yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo­thio­phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromo­thio­phen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C—H⋯N inter­actions link the mol­ecules into infinite C(7) chains along the 2(1) axes.
format Online
Article
Text
id pubmed-3998606
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-39986062014-05-13 4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole Geiger, H. Cristina Donohoe, James S. Geiger, David K. Acta Crystallogr Sect E Struct Rep Online Organic Papers The title compound, C(18)H(13)Br(3)N(2)S(2), was obtained via the reaction of N-bromo­succinamide with 5,6-dimethyl-2-(thio­phen-2-yl)-1-[(thio­phen-2-yl)meth­yl]-1H-benzimidazole. The compound exhibits rotational disorder of the 5-bromo­thio­phen-2-yl substituent with a refined major:minor occupancy ratio of 0.876 (7):0.124 (7). The 5-bromo­thio­phen-2-yl mean plane is canted to the benzimidazole plane by 20.0 (4) and 21 (4)° in the major and minor components, respectively. In the crystal, weak C—H⋯N inter­actions link the mol­ecules into infinite C(7) chains along the 2(1) axes. International Union of Crystallography 2014-03-26 /pmc/articles/PMC3998606/ /pubmed/24826179 http://dx.doi.org/10.1107/S160053681400628X Text en © Geiger et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Organic Papers
Geiger, H. Cristina
Donohoe, James S.
Geiger, David K.
4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole
title 4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole
title_full 4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole
title_fullStr 4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole
title_full_unstemmed 4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole
title_short 4-Bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1H-benzimidazole
title_sort 4-bromo-2-(5-bromo­thio­phen-2-yl)-1-[(5-bromo­thio­phen-2-yl)meth­yl]-5,6-dimethyl-1h-benzimidazole
topic Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998606/
https://www.ncbi.nlm.nih.gov/pubmed/24826179
http://dx.doi.org/10.1107/S160053681400628X
work_keys_str_mv AT geigerhcristina 4bromo25bromothiophen2yl15bromothiophen2ylmethyl56dimethyl1hbenzimidazole
AT donohoejamess 4bromo25bromothiophen2yl15bromothiophen2ylmethyl56dimethyl1hbenzimidazole
AT geigerdavidk 4bromo25bromothiophen2yl15bromothiophen2ylmethyl56dimethyl1hbenzimidazole